SMAD3 and neoplasm: These findings suggest that SPTBN1 silencing can alleviate ammonia toxicity, attenuate oncogenic transcriptional programs, and restore tumor-suppressive TGF-β–SMAD3 signaling (Figs. 3D and S6).